Willow Biosciences Inc. (WLLW.TO)

CAD 0.06

(-20.0%)

Market Cap (In CAD)

8.65 Million

Revenue (In CAD)

1.17 Million

Net Income (In CAD)

-13.02 Million

Avg. Volume

101.62 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.06-0.145
PE
-
EPS
-
Beta Value
1.136
ISIN
CA97111B4047
CUSIP
97111B404
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Chris Savile
Employee Count
-
Website
https://www.willowbio.com
Ipo Date
2021-02-11
Details
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.